Peginterferon alfa-2b and ribavirin treatment response among Hispanic veterans with chronic hepatitis C genotype 1

被引：1
|
作者：
Toro, D [1 ]
De Jesus, JJ [1 ]
Rodriguez-Perez, F [1 ]
Gonzalez, D [1 ]
Rivera, I [1 ]
机构：
[1] San Juan Vet Affairs Med Ctr, San Juan, PR USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2005年 / 100卷 / 09期
关键词：
D O I：
10.14309/00000434-200509001-00301
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
301
引用
收藏
页码：S122 / S123
页数：2
相关论文
共 50 条
  • [21] Pegylated interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C genotype
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Owaid, SF
    Al-Ajmi, M
    Al-Nakib, B
    [J]. HEPATOLOGY, 2003, 38 (04) : 629A - 629A
  • [22] Peginterferon alfa-2a and peginterferon alfa-2b combined with ribavirin in patients with genotype 1 chronic hepatitis C: Results of a prospective single-centre study
    Berak, Hanna
    Laskus, Tomasz
    Kolakowska-Rzadzka, Anna
    Wasilewski, Marek
    Stanczak, Janusz J.
    Bardadin, Krzysztof
    Walewska-Zielecka, Bozena
    Horban, Andrzej
    [J]. ADVANCES IN MEDICAL SCIENCES, 2014, 59 (02): : 261 - 265
  • [23] Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin
    Brixner, Diana I.
    Ye, Xin
    Chu, Teng-Chiao
    Blumentals, William A.
    Hassanein, Tarek I.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (24) : 2171 - 2178
  • [24] Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin
    Rustgi, V. K.
    Esposito, S.
    Hamzeh, F. M.
    Shiffman, M. L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (05) : 433 - 440
  • [25] PATIENT REPORTED OUTCOMES AMONG CHRONIC HEPATITIS C PATIENTS RETREATED WITH PEGINTERFERON ALFA-2A/RIBAVIRIN AFTER NON-RESPONSE TO PEGINTERFERON ALFA-2B/RIBAVIRIN IN SPAIN
    Olveira, A.
    Rincon, D.
    Diago, M.
    Crespo, J.
    Calleja, J. L.
    Salmeron, J.
    Andrade, R.
    Romero, M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A282 - A282
  • [26] Treatment with combination peginterferon alfa-2b and ribavirin of recurrent hepatitis C in liver transplant recipients nonresponsive to interferon alfa-2b and ribavirin
    Samanta, A
    Mandalapu, A
    Fisher, A
    Wilson, D
    de la Torre, A
    Klein, KM
    Koneru, B
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A455 - A456
  • [27] Effect of treatment management algorithms on ribavirin and peginterferon alfa-2b costs for chronic hepatitis C.
    Wong, JB
    Davis, GL
    McHutchison, JG
    Manns, MP
    Albrecht, JK
    [J]. HEPATOLOGY, 2002, 36 (04) : 294A - 294A
  • [28] Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium
    Wong, JB
    Nevens, F
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2002, 65 (02): : 110 - 111
  • [29] Tongue Hyperpigmentation Resulting from Peginterferon Alfa-2b and Ribavirin Treatment in a Patient with Chronic Hepatitis C
    Souvik Ghosh
    Ajay Duseja
    Radha Krishan Dhiman
    Yogesh Kumar Chawla
    [J]. Digestive Diseases and Sciences, 2012, 57 : 820 - 821
  • [30] THALIDOMIDE WITH PEGINTERFERON ALFA-2B AND RIBAVIRIN IN THE TREATMENT OF NON-RESPONDERS GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS (TRITAL): PROOF OF CONCEPT
    Pardo, Benjamin
    Garcia-Collado, Carlos
    Grande, Lourdes
    Paradas, Car-men
    Rodriguez-Lopez, Olga
    Morillo, Ramon
    Hoyas, Elena
    Artacho Criado, Silvia
    Dorantes, Benito
    Romero-Gomez, Manuel
    [J]. HEPATOLOGY, 2009, 50 (04) : 722A - 722A
12345